A Pilot Study of KPL-914 in Recurrent Pericarditis
Phase 2
Completed
- Conditions
- Recurrent Pericarditis
- Interventions
- Drug: KPL-914
- First Posted Date
- 2019-06-10
- Last Posted Date
- 2021-05-27
- Lead Sponsor
- Kiniksa Pharmaceuticals (UK), Ltd.
- Target Recruit Count
- 26
- Registration Number
- NCT03980522
- Locations
- 🇺🇸
Research Integrity, LLC, Owensboro, Kentucky, United States
🇺🇸Cleveland Clinic, Cleveland, Ohio, United States
🇺🇸Franciscan Physician Network Indiana Heart Physicians Cardiovascular Research Program, Indianapolis, Indiana, United States
Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis
- First Posted Date
- 2018-11-09
- Last Posted Date
- 2023-09-06
- Lead Sponsor
- Kiniksa Pharmaceuticals (UK), Ltd.
- Target Recruit Count
- 86
- Registration Number
- NCT03737110
- Locations
- 🇺🇸
Arthritis and Rheumatology of Georgia, Atlanta, Georgia, United States
🇺🇸The Loretto Hospital, Chicago, Illinois, United States
🇺🇸Cleveland Clinic, Cleveland, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath